Background Identification of patients at high risk of treatment-resistant schizophrenia at the
time of schizophrenia diagnosis would be of great clinical benefit in minimising the delay to …

Despite its unsurpassed efficacy in treatment-resistant schizophrenia, clozapine remains
underutilized. Trends in the prescription of clozapine in patients with ICD-10 F20. x …

Most current pharmacologic antidepressant treatments target either or both serotonin and
norepinephrine systems in the brain to alleviate depressive symptoms. However,≥ 30% of …

Background Cognitive deficits are prevalent in people with schizophrenia and associated
with functional impairments. In addition to antipsychotics, pharmacotherapy in schizophrenia …

Background: There is a lack of national level data from India on prescription of psychotropics
by psychiatrists. Aim and Objective: This study aimed to assess the first prescription handed …

Background: Although almost all psychotropic medications available worldwide are readily
available in India, there is meager data in this country on the prescription patterns of …

Objective The objective was to investigate the status of oral health and its determinants in a
group of psychiatric inpatients in central Taiwan. Method A cross-sectional study of the oral …

Second-generation antipsychotics (SGAs) increase the risk of metabolic syndrome (MetS).
Although ethnicity also contributes to MetS risk, the majority of the studies on the relationship …

Providing optimal care to patients with recent‐onset psychosis can improve outcomes and
reduce relapse. However, there is a lack of consistency of the implementation of guidelines …

Benzodiazepines are commonly prescribed to patients with schizophrenia in many
countries, but as little is known about such treatment in Asia, we evaluated their adjunctive …